ArticleFrontiers in cardiovascular medicine2022

MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice.

Menglong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.